Search

everythinglearnresearchcommunity

for

Search:↓

Steroid-producing capabilities in certain cancers may contribute to treatment resistance.

The article concludes that hormonal therapy is an effective long-term acne treatment, even for those without hormonal imbalances.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Stress can worsen skin conditions by affecting hormone levels and immune response.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

PCOS is linked to inflammation, and certain markers could help in its treatment.

The article suggests renaming Polycystic Ovarian Syndrome (PCOS) to "Hyperandrogenic Persistent Ovulatory Dysfunction Syndrome" (HA-PODS) for accuracy and consistency, but no final decision was made.

Androgenetic alopecia is common hair loss due to genetics and DHT.

Steroidogenic isoenzymes may help improve treatments for common hair loss.

Foxn1 is crucial for skin development and healing, and altering its expression may aid regenerative medicine.

The skin acts like an endocrine organ, producing hormones that affect various body functions and skin health, and understanding this can lead to new treatments.

Polycystic Ovary Syndrome (PCOS) is common in women with conditions like anovulation, hirsutism, hair loss, and type 2 diabetes, and it can lead to health risks like heart disease, obesity, insulin resistance, and depression. Non-Classic Congenital Adrenal Hyperplasia (NC-CAH) is also discussed.

Men with baldness have higher levels of specific proteins, suggesting local hormone production may play a role in hair loss.

The review concludes that innovations in regenerative medicine, tissue engineering, and developmental biology are essential for effective tissue repair and organ transplants.

The hypothesis suggests that PCOS may start early in life due to genetic and environmental factors, influencing future reproductive and metabolic problems.

High fasting insulin levels in women with PCOS are linked to a higher risk of heart and metabolic problems.

SHBG may be a useful early indicator and treatment target for PCOS.

Treating PCOS is complex, involving medication like metformin and lifestyle changes, and requires attention to mental health due to high depression and anxiety rates.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

The document concludes that more research is needed to fully understand the causes of PCOS.

The document concludes that early diagnosis and treatment of PCOS in teenagers is important for managing symptoms and preventing long-term health problems.

Many young Egyptian women with PCOS also have fatty liver disease, especially if they are overweight and insulin resistant.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

PCOS is often linked to insulin resistance and obesity, and weight loss can improve symptoms.

Lower levels of certain brain chemicals are linked to worse PTSD symptoms in men.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.